Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC‐QTOF‐MS/MS platform

• Published in: Electrophoresis Vol. 38; no. 18; pp. 2341 - 2348
• Main Authors: Ferrarini, Alessia, Righetti, Laura, Martínez, Ma Paz, Fernández‐López, Mariano, Mastrangelo, Annalaura, Horcajada, Juan P., Betbesé, Antoni, Esteban, Andrés, Ordóñez, Jordi, Gea, Joaquín, Cabello, Jesús Ruiz, Pellati, Federica, Lorente, José A., Nin, Nicolás, Rupérez, Francisco J.
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.09.2017
• Subjects: Adult; Aged; ARDS; Biomarkers; Chromatography, High Pressure Liquid - methods; Cohort Studies; Female; Humans; Infections; Influenza; Influenza A (H1N1) virus infection; Influenza A Virus, H1N1 Subtype; Influenza, Human - blood; Influenza, Human - virology; Male; Metabolism; Metabolites; Metabolome; Metabolomics - methods; Middle Aged; Pathogenesis; Patients; Respiratory distress syndrome; Respiratory Distress Syndrome, Adult - blood; Respiratory Distress Syndrome, Adult - virology; Respiratory therapy; Swine flu; Tandem Mass Spectrometry - methods; Thyroxine; Tryptophan; Untargeted metabolomics; Viruses; Biomarkers; Pathogenesis; Influenza A (H1N1) virus infection; ARDS; Untargeted metabolomics
• ISSN: 0173-0835; 1522-2683
• DOI: 10.1002/elps.201700112

Acute respiratory distress syndrome (ARDS) is a serious complication of influenza A (H1N1) virus infection. Its pathogenesis is unknown and biomarkers are lacking. Untargeted metabolomics allows the analysis of the whole metabolome in a biological compartment, identifying patterns associated with specific conditions. We hypothesized that LC‐MS could help identify discriminant metabolites able to define the metabolic alterations occurring in patients with influenza A (H1N1) virus infection that developed ARDS. Serum samples from patients diagnosed with 2009 influenza A (H1N1) virus infection with (n = 25) or without (n = 32) ARDS were obtained on the day of hospital admission and analyzed by LC‐MS/MS. Metabolite identification was determined by MS/MS analysis and analysis of standards. The specificity of the patterns identified was confirmed in patients without 2009 influenza A(H1N1) virus pneumonia (15 without and 17 with ARDS). Twenty‐three candidate biomarkers were found to be significantly different between the two groups, including lysophospholipids and sphingolipids related to inflammation; bile acids, tryptophan metabolites, and thyroxine, related to the metabolism of the gut microflora. Confirmation results demonstrated the specificity of major alterations occurring in ARDS patients with influenza A (H1N1) virus infection.